SRP19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.642400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.138600E-01
Normal-vs-Stage2
6.146000E-01
Normal-vs-Stage3
5.569800E-01
Normal-vs-Stage4
4.414200E-01
Stage1-vs-Stage2
2.574600E-01
Stage1-vs-Stage3
3.130600E-01
Stage1-vs-Stage4
4.799800E-01
Stage2-vs-Stage3
6.964000E-01
Stage2-vs-Stage4
7.462100E-02
Stage3-vs-Stage4
2.493600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.296000E-01
Normal-vs-AfricanAmerican
3.912000E-01
Normal-vs-Asian
4.565400E-01
Caucasian-vs-AfricanAmerican
3.120600E-01
Caucasian-vs-Asian
2.922400E-01
AfricanAmerican-vs-Asian
8.538800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.297400E-01
Normal-vs-Female
8.295400E-01
Male-vs-Female
5.625200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.810000E-01
Normal-vs-Age(41-60Yrs)
8.305000E-01
Normal-vs-Age(61-80Yrs)
5.811200E-01
Normal-vs-Age(81-100Yrs)
7.831800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.529000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.667600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.807400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.280200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.189000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.812000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.796400E-01
Normal-vs-Daily Drinker
2.250800E-01
Normal-vs-Weekly Drinker
8.703000E-01
Normal-vs-Occasional Drinker
7.280400E-01
Normal-vs-Social Drinker
7.704800E-01
Non Drinker-vs-Daily Drinker
3.498800E-01
Non Drinker-vs-Weekly Drinker
5.929600E-01
Non Drinker-vs-Occasional Drinker
7.928000E-02
Non Drinker-vs-Social Drinker
5.682600E-01
Daily Drinker-vs-Weekly Drinker
2.817400E-01
Daily Drinker-vs-Occasional Drinker
1.236190E-02
Daily Drinker-vs-Social Drinker
1.327830E-01
Weekly Drinker-vs-Occasional Drinker
3.995400E-01
Weekly Drinker-vs-Social Drinker
9.594200E-01
Occasional Drinker-vs-Social Drinker
2.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.065200E-01
Normal-vs-Grade 2
9.158000E-01
Normal-vs-Grade 3
9.316800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.779200E-01
Grade 1-vs-Grade 3
7.034600E-01
Grade 1-vs-Grade 4
9.065200E-01
Grade 2-vs-Grade 3
6.590000E-01
Grade 2-vs-Grade 4
9.158000E-01
Grade 3-vs-Grade 4
9.316800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.036000E-01
Normal-vs-NonDiabetic
7.357200E-01
Diabetic-vs-NonDiabetic
5.555800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.214000E-01
Normal-vs-NoPancreatitis
7.452000E-01
Pancreatitis-vs-NoPancreatitis
5.645400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.838400E-01
Normal-vs-N1
6.322000E-01
N0-vs-N1
9.065500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.203800E-01
Normal-vs-TP53-NonMutant
8.012600E-01
TP53-Mutant-vs-TP53-NonMutant
5.436800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
